KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Gross Profit (2016 - 2026)

Medtronic (MDT) has disclosed Gross Profit for 13 consecutive years, with $5.8 billion as the latest value for Q1 2026.

  • Quarterly Gross Profit rose 4.41% to $5.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $23.0 billion through Jan 2026, up 6.2% year-over-year, with the annual reading at $21.9 billion for FY2025, 3.58% up from the prior year.
  • Gross Profit hit $5.8 billion in Q1 2026 for Medtronic, down from $5.9 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $5.9 billion in Q4 2025 to a low of $4.9 billion in Q3 2022.
  • Historically, Gross Profit has averaged $5.4 billion across 5 years, with a median of $5.5 billion in 2024.
  • Biggest five-year swings in Gross Profit: decreased 9.91% in 2022 and later grew 8.21% in 2025.
  • Year by year, Gross Profit stood at $5.1 billion in 2022, then increased by 3.43% to $5.2 billion in 2023, then grew by 4.48% to $5.5 billion in 2024, then grew by 8.12% to $5.9 billion in 2025, then decreased by 2.44% to $5.8 billion in 2026.
  • Business Quant data shows Gross Profit for MDT at $5.8 billion in Q1 2026, $5.9 billion in Q4 2025, and $5.6 billion in Q3 2025.